On 20 October 2016, as part of the two-year funding package imposed on community pharmacies in England, the Department of Health confirmed the introduction of a Pharmacy Access Scheme (PhAS), with the stated aim of ensuring that a baseline level of patient access to NHS community pharmacy services is protected. This briefing details the key points on PhAS works and the review process.

PSNC Briefing 005/17: The Pharmacy Access Scheme – the review process closes at the end of February 2017*

*This is subject to one exception relating to physical feature anomalies described in the briefing.

If you have any queries on this PSNC Briefing or you require more information, please contact Layla Rahman, Regulations Officer.

To browse other PSNC Briefings on Contract and IT, click here.